Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Nonalcoholic steatohepatitis (NASH) reflects severe liver disease within the NAFLD spectrum and can progress to end-stage liver disease. Within this manuscript we review the available evidence for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouzaki, Marialena, Allard, Johane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2012
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959359/
https://www.ncbi.nlm.nih.gov/pubmed/24713803
_version_ 1782308028197896192
author Mouzaki, Marialena
Allard, Johane
author_facet Mouzaki, Marialena
Allard, Johane
author_sort Mouzaki, Marialena
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Nonalcoholic steatohepatitis (NASH) reflects severe liver disease within the NAFLD spectrum and can progress to end-stage liver disease. Within this manuscript we review the available evidence for the treatment of NASH as well as the newer therapeutic agents that are currently being investigated.
format Online
Article
Text
id pubmed-3959359
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hellenic Society of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-39593592014-04-07 Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic Mouzaki, Marialena Allard, Johane Ann Gastroenterol Invited Review Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Nonalcoholic steatohepatitis (NASH) reflects severe liver disease within the NAFLD spectrum and can progress to end-stage liver disease. Within this manuscript we review the available evidence for the treatment of NASH as well as the newer therapeutic agents that are currently being investigated. Hellenic Society of Gastroenterology 2012 /pmc/articles/PMC3959359/ /pubmed/24713803 Text en Copyright: © Hellenic Society of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Invited Review
Mouzaki, Marialena
Allard, Johane
Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic
title Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic
title_full Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic
title_fullStr Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic
title_full_unstemmed Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic
title_short Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic
title_sort non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic
topic Invited Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959359/
https://www.ncbi.nlm.nih.gov/pubmed/24713803
work_keys_str_mv AT mouzakimarialena nonalcoholicsteatohepatitisthetherapeuticchallengeofaglobalepidemic
AT allardjohane nonalcoholicsteatohepatitisthetherapeuticchallengeofaglobalepidemic

Ejemplares similares